Prevalence and risk factors of metabolic syndrome in obese and non-obese South Indian adults: A population-based cross-sectional study
Keywords:
metabolic syndrome, risk factors, prevalence, obesity, non-obese adults, cross-sectional studies, epidemiology, south IndiaAbstract
Background and aim: Metabolic syndrome (MetS), a cluster of risk factors associated with various noncommunicable diseases, has traditionally been linked to obesity. However, recent studies have demonstrated high MetS prevalence among non-obese individuals, with evidence suggesting distinct patterns of lifestyle risk factors between obese and non-obese populations. This study aims to estimate the prevalence of MetS in non-obese individuals and investigate the independent associations between lifestyle risk factors and MetS in both obese and non-obese populations.
Methods: A total of 443 participants were recruited, comprising 177 non-obese and 266 obese individuals in this study. Data were collected on family history, physical activity levels, smoking status, alcohol consumption patterns, and dietary intake of fruits and vegetables. Obesity was classified according to Asia-Pacific criteria, with non-obese defined as (BMI <25 Kg/m²).
Results: MetS affected 58.91% of all study participants, with a substantial 40.7% occurrence, even among those who were not obese. The presence of Type 2 diabetes mellitus(T2DM) demonstrated a strong correlation with MetS, regardless of whether individuals were classified as obese or non-obese. Among obese participants, a history of cardiovascular disease (CVD) showed a significant association with MetS, while in non-obese participants, sex and family history of T2DM were significantly associated with MetS.
Conclusions: Our study population showed a notable prevalence of MetS, extending significantly beyond just those participants with obesity. This suggests the need for MetS screening in both obese and non-obese populations to ensure timely detection and management of MetS.
References
1. Bowo-Ngandji A, Kenmoe S, Ebogo-Belobo JT, et al. Prevalence of the metabolic syndrome in African populations: a systematic review and meta-analysis. PLoS One. 2023;18:1–34. doi: 10.1371/journal.pone.0289155
2. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–11. doi: 10.2337/dc12-0336
3. Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16(1):1–10. doi: 10.1186/s12889-016-2870-y
4. Chowdhury MZI, Anik AM, Farhana Z, et al. Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health. 2018;18(1):308. doi: 10.1186/s12889-018-5209-z
5. Krishnamoorthy Y, Rajaa S, Murali S, et al. Prevalence of metabolic syndrome among adult population in India: a systematic review and meta-analysis. PLoS One. 2020;15(10):e0240971. doi: 10.1371/journal.pone.0240971
6. Ranasinghe P, Rathnayake N, Wijayawardhana S, et al. Rising trends of diabetes in South Asia: a systematic review and meta-analysis. Diabetes Metab Syndr. 2024;18(11–12):103160. doi: 10.1016/j.dsx.2024.103160
7. Liu J, Bai R, Chai Z, et al. Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data. Diabetologia. 2022;65(8):1339–52. doi: 10.1007/s00125-022-05713-6
8. Musilanga N, Nasib H, Jackson G, et al. Exploring the prevalence and components of metabolic syndrome in Sub-Saharan African type 2 diabetes mellitus patients: a systematic review and meta-analysis. J Obes. 2024;2024:1240457. doi: 10.21203/rs.3.rs-3958331/v1
9. World Health Organization. Non-communicable diseases. 2023 [cited 2025 Jan]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
10. Mukhopadhyay P, Ghosh S, Bhattacharjee K, et al. Lean metabolic syndrome: a concept or a reality? Indian J Endocrinol Metab. 2018;22(3):303–7. doi: 10.4103/ijem.IJEM_639_17
11. Chaudhary P, Goyal A, Pakhare A, et al. Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India. Sleep Breath. 2022;26(2):681–8. doi: 10.1007/s11325-021-02401-4
12. Geetha L, Deepa M, Anjana RM, Mohan V. Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol. 2011;5(2):439–46. doi: 10.1177/193229681100500235
13. Lee SC, Hairi NN, Moy FM. Metabolic syndrome among non-obese adults in the teaching profession in Melaka, Malaysia. J Epidemiol. 2017;27(3):130–4. doi: 10.1016/j.je.2016.10.006
14. Suliga E, Kozieł D, Głuszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med. 2016;23(4):631–5. doi: 10.5604/12321966.1226858
15. Osadnik K, Osadnik T, Lonnie M, et al. Metabolically healthy obese and metabolic syndrome of the lean: the importance of diet quality. Analysis of MAGNETIC cohort. Nutr J. 2020;19(1):1–13. doi: 10.1186/s12937-020-00532-0
16. Vikram NK, Pandey RM, Misra A, et al. Non-obese (body mass index <25 kg/m²) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition. 2003;19(6):503–9. doi: 10.1016/S0899-9007(02)01083-3
17. Kapoor N, Lotfaliany M, Sathish T, et al. Prevalence of normal weight obesity and its associated cardio-metabolic risk factors – results from the baseline data of the Kerala Diabetes Prevention Program (KDPP). PLoS One. 2020;15(8):e0237974. doi: 10.1371/journal.pone.0237974
18. Aung KK, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462–8. doi: 10.1210/jc.2013-2832
19. Kim NH, Seo JA, Cho H, et al. Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people. Medicine (Baltimore). 2016;95(15):e3384. doi: 10.1097/MD.0000000000003384
20. Barik D, Arokiasamy P. Rising health expenditure due to non-communicable diseases in India: an outlook. Front Public Health. 2016;4:268. doi: 10.3389/fpubh.2016.00268
21. Sabaté J, Wien M. A perspective on vegetarian dietary patterns and risk of metabolic syndrome. Br J Nutr. 2015;113(S2):S136–43. doi: 10.1017/S0007114514004139
22. Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One. 2012;7(10):e47791. doi: 10.1371/journal.pone.0047791
23. Åberg F, Byrne CD, Pirola CJ, et al. Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol. 2023;78(1):191–206. doi: 10.1016/j.jhep.2022.08.030
24. Tian Y, Su L, Wang J, et al. Fruit and vegetable consumption and risk of the metabolic syndrome: a meta-analysis. Public Health Nutr. 2018;21(4):756–65. doi: 10.1017/S136898001700310X
25. Kikuchi A, Monma T, Ozawa S, et al. Risk factors for multiple metabolic syndrome components in obese and non-obese Japanese individuals. Prev Med. 2021;153:106855. doi: 10.1016/j.ypmed.2021.106855
26. World Health Organization. Appropriate body-mass index for Asian populations and its implications. Lancet. 2004;363:157–63. doi: 10.1016/S0140-6736(03)15268-3
27. World Health Organization. The WHO STEPwise approach to chronic disease risk factor surveillance. WHO STEPS Surveill Man. 2005:490. Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps
28. World Health Organization. Global Physical Activity Questionnaire (GPAQ) Version 2.0. Available from: https://www.who.int/publications/m/item/global-physical-activity-questionnaire
29. Tian Y, Liu J, Zhao Y, et al. Alcohol consumption and all-cause and cause-specific mortality among US adults: prospective cohort study. BMC Med. 2023;21(1):1–15. doi: 10.1186/s12916-023-02907-6
30. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52. doi: 10.1161/CIRCULATIONAHA.105.169404
31. Subramani SK, Mahajan S, Chauhan P, et al. Prevalence of metabolic syndrome in Gwalior region of Central India: a comparative study using NCEP ATP III, IDF and Harmonized criteria. Diabetes Metab Syndr. 2019;13(1):816–21. doi: 10.1016/j.dsx.2018.12.003
32. Latha PS, Sangeetha S, Vijayakarthikeyan M, et al. Prevalence and influencing factors of metabolic syndrome among rural adult population in a district of South India. J Family Med Prim Care. 2024;13(8):3122–8. doi: 10.4103/jfmpc.jfmpc_1929_23
33. Negi PC, Sondhi S, Merwaha R, et al. Prevalence and risk determinants of metabolic syndrome in obese worksite workers in hill city of Himachal Pradesh, India. Indian Heart J. 2019;71(1):45–51. doi: 10.1016/j.ihj.2019.01.001
34. Mata AJ, Jasul G. Prevalence of metabolic syndrome and its individual features across different body mass index categories in a tertiary hospital in the Philippines. J ASEAN Fed Endocr Soc. 2017;32(2):117–22. doi: 10.15605/jafes.032.02.04
35. Krupp K, Adsul P, Wilcox ML, et al. Prevalence and correlates of metabolic syndrome among rural women in Mysore, India. Indian Heart J. 2020;72(6):582–8. doi: 10.1016/j.ihj.2020.09.015
36. Alipour P, Azizi Z, Raparelli V, et al. Role of sex and gender-related variables in development of metabolic syndrome: a prospective cohort study. Eur J Intern Med. 2024;121:63–75. doi: 10.1016/j.ejim.2023.10.006
37. Vatakencherry RMJ, Saraswathy L. Prevalence of metabolic syndrome among adults in a teaching hospital in Kochi, Central Kerala: a cross-sectional study. J Family Med Prim Care. 2019;8(6):2079–83. doi: 10.4103/jfmpc.jfmpc_241_19
38. Ying X, Yang S, Li S, et al. Prevalences of metabolic syndrome and its sex-specific association with socioeconomic status in rural China: a cross-sectional study. BMC Public Health. 2021;21(1):1–8. doi: 10.1186/s12889-021-12074-z
39. Vekic J, Zeljkovic A, Stefanovic A, et al. Obesity and dyslipidemia. Metabolism. 2019;92:71–81. doi: 10.1016/j.metabol.2018.11.005
40. Bays HE, Kirkpatrick CF, Maki KC, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association. J Clin Lipidol. 2024;18(3):e320–50. doi: 10.1016/j.jacl.2024.04.001
41. Krishna STR, Bahurupi Y, Kant R, et al. Prevalence of metabolic syndrome and its risk factors among newly diagnosed type 2 diabetes mellitus patients: a hospital-based cross-sectional study. J Family Med Prim Care. 2024;13(8):3325–31. doi: 10.4103/jfmpc.jfmpc_51_24
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Raju Rana, Shobha U Kamath, B Ananthakrishna Shastri, Shashikiran U, G Arun Maiya, Ullas Kamath, Raghavendra Rao S, Vani Lakshmi R
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
